Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement. Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint, including analgesics, nonsteroidal anti-inflammatory drugs, corticosteroids, hyaluronic acid, and phase III drugs.
This report contains market size and forecasts of Osteoarthritis Drugs in global, including the following market information:
Global Osteoarthritis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Osteoarthritis Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Osteoarthritis Drugs companies in 2021 (%)
The global Osteoarthritis Drugs market was valued at 5636 million in 2021 and is projected to reach US$ 7570.9 million by 2028, at a CAGR of 4.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Osteoarthritis Drugs include Johnson & Johnson, Pfizer, Eli Lilly, Abbott, GlaxoSmithKline, Sanofi and Flexion Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Osteoarthritis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Osteoarthritis Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Osteoarthritis Drugs Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
External
Global Osteoarthritis Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Osteoarthritis Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Osteoarthritis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Osteoarthritis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Osteoarthritis Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Osteoarthritis Drugs revenues share in global market, 2021 (%)
Key companies Osteoarthritis Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Osteoarthritis Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Pfizer
Eli Lilly
Abbott
GlaxoSmithKline
Sanofi
Flexion Therapeutics